Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-18-000008
Filing Date
2018-07-18
Accepted
2018-07-18 20:44:45
Documents
1
Period of Report
2018-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_153196106996341.html 3  
1 FORM 3 wf-form3_153196106996341.xml 3 7618
  Complete submission text file 0001722024-18-000008.txt   9252
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101
Business Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38584 | Film No.: 18959363